Goldman Sachs Group »

Carisma Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $31k 11k 2.93
2023-09-30 $54k 13k 4.23
2023-06-30 $243k 28k 8.77